BENCHMARKS REPORT
Industry Measure: Company Level Data
| SIC: | 2836 |
| INDUSTRY: | BIOLOGICAL PRODUCTS (EXC DIAGNOSTIC) |
| BENCHMARKS FOR THE INDUSTRY |
| NO. OF SEGMENTS REPORTING IN THE INDUSTRY: 112 |
|
1997 SALES FOR THE INDUSTRY: $ 6961 (Total Sales in $Millions) |
|
OPERATING MARGIN: 1.6 (EBIT (divided by) Sales) |
|
CAPITAL INTENSITY: 158.1 (Sum of Total Debt plus Shareholder Equity (divided by) Sales) |
|
SALES GROWTH: 36.4 (Compound 3-Year Growth Rate in Sales for the Median Participant in the Industry) |
| BENCHMARKS FOR THE TOP FOUR COMPETITORS |
| ROE: Net Profits (divided by) Total Shareholder Equity RONCE: EBIT (divided by) Sum of Total Debt plus Shareholders' Equity |
| Competitor/Rank by Sales |
Market Share (% Ind. Sales) |
ROE | RONCE |
| #1: AMGEN INC |
34.5 | 30.1 | 36.5 |
| #2: SIGMA-ALDRICH |
16.2 | 15.7 | 23.7 |
| #3: GENZYME GENERAL |
8.6 | 7.9 | 9.0 |
| #4: BIOGEN INC |
5.9 | 16.6 | 22.0 |
| Total of #1-4: | 65.2 | -5.4 | 1.0 |